Inhaler use for cough
Pro Research Analysisby 
Searched over 200M research papers
Inhaler Use for Cough: Effectiveness and Considerations
Inhaled Corticosteroids and Bronchodilators for Cough Relief
Inhaled medications, especially corticosteroids and bronchodilators, are commonly used to manage cough associated with asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Studies show that inhaled corticosteroids like budesonide-formoterol and fluticasone propionate are effective in reducing cough symptoms in both adults and children with cough variant asthma, with most patients experiencing significant improvement in cough control and quality of life after treatment 4510. Longer treatment durations (at least six months) with inhaled corticosteroids in children are associated with lower relapse rates after stopping the medication, without significant safety concerns .
Bronchodilator inhalers, such as terbutaline, are also effective for rapid cough suppression in COPD patients and can even suppress cough induced by medications like fentanyl 26. Both lidocaine and bronchodilator inhalation treatments provide similar short-term relief for intractable cough in COPD, with only mild and manageable side effects .
Inhaler Device Type and Technique: Impact on Cough and Treatment Efficacy
The type of inhaler device—dry powder inhaler (DPI) versus pressurized metered dose inhaler (MDI)—does not significantly affect the overall efficacy of cough treatment in cough variant or cough predominant asthma. However, switching inhaler types combined with proper inhalation technique training can further improve asthma control and reduce cough severity . Correct inhaler technique is crucial; improper use is linked to worse symptom control, more frequent cough, and poorer lung function, especially in COPD patients . Regular training and assessment of inhaler technique are recommended to maximize treatment benefits and minimize cough 17.
Inhaler-Induced Cough: Causes and Prevention
Cough can also be a side effect of inhaled medications. Factors such as the type of inhaler device, drug formulation, dose, excipients, and aerosol characteristics (like pH and particle size) can trigger cough by stimulating airway receptors. This effect is more pronounced in patients with bronchoconstriction or inflamed airways, potentially reducing drug delivery to the lungs . Proper inhaler selection, formulation, and technique can help minimize these adverse effects 13.
Novel and Combination Inhaler Therapies for Chronic Cough
For patients with persistent cough despite standard inhaled corticosteroid/long-acting beta2-agonist (ICS/LABA) therapy, new combination inhalers (such as indacaterol/glycopyrronium/mometasone) are being studied for their potential to further improve cough-specific quality of life . Additionally, novel inhaled formulations like sodium cromoglicate (PA101) have shown promise in reducing cough frequency in patients with idiopathic pulmonary fibrosis, though not in those with chronic idiopathic cough, suggesting disease-specific responses .
Conclusion
Inhaler use is effective for managing cough in asthma, COPD, and certain other respiratory conditions, with both corticosteroids and bronchodilators providing significant symptom relief. The choice of inhaler device is less important than ensuring correct inhalation technique and appropriate patient training. While inhaled medications can sometimes provoke cough, careful selection of device and formulation, along with regular technique assessment, can help optimize outcomes and minimize side effects. Emerging therapies and combination inhalers may offer additional options for patients with persistent cough.
Sources and full results
Most relevant research papers on this topic